Pfizer Update on COVID-19 Vaccine Distribution
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
COVID-19 SCIENTIFIC RESOURCES
The Colleague & Dad Who Keeps Our Medicines and Vaccines on Ice
Find a Trial
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
THE ANTIGEN: #COVID19 PODCAST
VISIT OUR COVID-19 HUB
Latest News
New York and Mainz, Germany, January 20, 2021 — Today , Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results f rom an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, to neutralize the SARS-CoV-2 U.K. strain, also known as B.1.1.7 lineage or VOC 202012/01. The results were published on the preprint server b ioRxi v and submitted to a peer-reviewed journal. The B.1.1.7…